glp 1 and gut microbiome Bidirectional Interactions Between the Microbiota Incretin-Based Therapies Role of the gut–brain axis

GLP-1 receptor agonists remain legal and FDA-approved for weight loss and diabetes

5 77% of physicians surveyed said they had prescribed a GLP-1 in the past year, while 93% said they expect to prescribe more GLP-1s for weight loss going forward

The anti-inflammatory properties of glucagon like peptide-1 receptor agonists The glucagon like peptide-1 receptor agonists (GLP-1 RAs) are a glucose-lowering class of drugs that acts by mimicking the native GLP1 action, a peptide hormone synthesized by bowel endocrine L-cells and physiologically degraded by dipeptidyl-peptidase 4

u003cstrongu003eWhat is the correct Ozempic microdose?u003c/strongu003e There is no single correct Ozempic microdose, but many patients begin at a fractional amount like 0.13 mg to introduce the drug gently